Schedule 13D ownership disclosure

Mirna Therapeutics, Inc.

Security class unavailable · CUSIP: 60470J103

Event date: 2017-05-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,987,947
Percent of class
32.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-17-034591
Form type
SC 13D
Filer
SYNLOGIC, INC.
CIK
CIK 1527599
Filed
May 23, 2017
Reporting period
May 15, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub